Human coronavirus NL63 (HCoV-NL63) is an alphacoronavirus that was first 33 identified in 2004 in the nasopharyngeal aspirate from a 7-month-old patient with a 34 respiratory tract infection. Previous studies showed that HCoV-NL63 and the genetically 35 distant SARS-CoV employ the same receptor for host cell entry, angiotensin converting 36 enzyme 2 (ACE2), but it is largely unclear whether ACE2 interactions are sufficient to allow 37 HCoV-NL63 binding to cells. The present study showed that directed expression of 38 angiotensin-converting enzyme 2 (ACE2) on cells previously resistant to HCoV-NL63 39 renders them susceptible, showing that ACE2 protein acts as a functional receptor and its 40 expression is required for infection. However, comparative analysis showed that directed 41 expression or selective scission of the ACE2 protein had no measurable effect on virus 42 adhesion. In contrast, binding of HCoV-NL63 to heparan sulfates was required for viral 43 attachment and infection of target cells, showing that these molecules serve as attachment IMPORTANCE 46 ACE2 protein has been proposed as a receptor for HCoV-NL63 already in 2005, but the 47 in-depth analysis of early events during virus infection was not performed thus far. Here, we 48 show that the ACE2 protein is required for viral entry, but it is not the primary binding site on 49 the cell surface. Conducted research showed that heparan sulfate proteoglycans function as 50 adhesion molecules, increasing the virus density on cell surface and possibly facilitating 51 interaction between HCoV-NL63 and its receptor. Obtained results show that the initial 52 events during HCoV-NL63 infection are more complex than anticipated and newly described 53 interaction may be essential for understanding the infection process and, possibly, also assist 54 in the drug design. 55 56 57 58 59 60 61 62 63 64 65 66 67 angiotensin converting enzyme 2, heparan sulfate proteoglycans, heparan sulfate.
INTRODUCTION
in Dulbecco's MEM supplemented with 10% heat-inactivated fetal bovine serum, penicillin 138 (100 U ml -1 ), streptomycin (100 μg ml -1 ), ciprofloxacin (5 μg ml -1 ) and puromycin (1 μg ml -1 ).
139
ACE2-expressing A549 cells (A549_ACE2 + ) were generated using retroviral vectors 140 that were based on the Moloney Murine Leukemia Virus system. Briefly, Phoenix-Ampho 141 cells (ATCC CRL-3213) were transfected with a pLNCX2 vector (Clontech, USA) encoding 142 the ACE2 protein using PEI. At 24 h post-transfection the medium was refreshed and the cells 143 were cultured for a further 24 h at 32°C. Subsequently, the vector-containing supernatants 144 were harvested, aliquoted, and stored at −80°C.
145
A549_WT cells were cultured in six-well plates (TPP, Switzerland) and infected with 146 1 ml of generated retroviruses in the presence of polybrene (5 μg ml -1 , Sigma-Aldrich). After 147 24 h incubation at 37°C, the cells were cultured medium supplemented with G418 (BioShop, 148 Canada; 5 mg ml -1 ) and passaged for 3 weeks at 37°C. Surviving clones were recovered and 149 analyzed as described below. A549_ACE2 + cells were maintained in Dulbecco's MEM 150 supplemented with 10% heat-inactivated fetal bovine serum, penicillin (100 U ml -1 ), 151 streptomycin (100 μg ml -1 ), ciprofloxacin (5 μg ml -1 ) and G418 (5 mg ml -1 ). 154 The HCoV-NL63 stock (isolate Amsterdam 1) was generated by infecting monolayers 155 of LLC-Mk2 cells. Cells were then lysed by two freeze-thaw cycles at 6 days 156 post-infection (p.i.). The virus-containing liquid was aliquoted and stored at −80°C. A control
153

Virus preparation, titration, and cell infection
In subsequent experiments, fully confluent cells (293T_WT/ACE2 + and 162 A549_WT/ACE2 + ) in six-well plates (TPP) were exposed to HCoV-NL63 at a TCID 50 ml -1 of 163 5 000. HCoV-NL63-permissive LLC-Mk2 cells were infected with the virus at a TCID 50 ml -1 164 of 400. Following a 2 h incubation at 32°C, unbound viruses were removed by washing with 165 sterile 1 × PBS and fresh medium was added to each well. Samples of cell culture supernatant 166 were collected every 24 h for 6 days and analyzed by real-time PCR. used as the reference dye. The reaction conditions were as follows: 2 min at 50°C and 10 min 178 at 92°C, followed by 40 cycles of 15 sec at 92°C and 1 min at 60°C.
180
Gradient purification of HCoV-NL63
181
The virus stock was concentrated 25-fold using centrifugal protein concentrators 182 (Amicon Ultra, 10 kDa cut-off; Merck, Poland) and subsequently layered onto a 15% 183 iodixanol solution in 1 × PBS (OptiPrep medium; Sigma-Aldrich, Poland). Following 184 centrifugation at 175 000 × g for 3 h at 4°C (cushion), virus-containing fractions were layered 185 onto a 10-20% iodixanol gradient (in 1 × PBS) and centrifuged at 175 000 × g for 18 h at 4°C. The PCR products were run on 1% agarose gels (1 × TAE buffer) and analyzed using Western blot analysis 212 Cells used for Western blot analysis were harvested at 5 days p.i. by scraping in ice-cold 213 1 × PBS. The cells were then centrifuged and resuspended in RIPA buffer (50 mM Tris, 214 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.5) followed 215 by lysis in RIPA buffer for 30 min on ice. Subsequently, samples were centrifuged (10 min at 216 12 000 × g) and the pelleted cell debris was discarded. Total protein concentration of each 217 sample was quantified using the BCA method and the resulting supernatants were mixed with 218 sample buffer (0.5 M Tris pH 6.8, 10% SDS, 50 mg/ml DTT), boiled for 5 min, cooled on ice, HCoV-NL63 or mock control for 2 h at 4°C. The cells were then washed with 1 × PBS, fixed 242 with 3% PFA, permeabilized with 0.1% Triton X-100 in 1 × PBS, and incubated for 1 h with 243 3% BSA/0.1% Tween 20 in 1 × PBS. To examine the HCoV-NL63 adhesion, cells were 244 mechanically detached from the plate surface and incubated for 2 h at room temperature with 245 a mouse anti-HCoV-NL63-N antibody (1 μg ml -1 ; Ingenansa, Spain), followed by a 1 h 246 incubation with an Alexa Fluor 488-labeled goat anti-mouse antibody (2.5 μg ml -1 ; Molecular 247 Probes). For ACE2 staining, cells were washed with 1 × PBS, scraped from the plates, and 248 incubated for 2 h at 4°C with goat anti-ACE2 ectodomain IgG (4 μg ml -1 ; R&D Systems, 249 USA), followed by a 1 h incubation with an FITC-labeled rabbit anti-goat IgG antibody 250 (13 μg ml -1 ; Dako, Denmark). Cells were then washed, resuspended in 1 × PBS and analyzed Confocal microscopy 255 LLC-Mk2 cells were seeded on coverslips in six-wells plates (TPP), cultured for 2 days 256 at 37°C and then stimulated with PMA (1 µM; Sigma-Aldrich, Poland) for 1 h at 37°C.
257
Subsequently, the cells were washed with 1 × PBS and incubated with iodixanol-concentrated 258 HCoV-NL63 or mock control for 2 h at 4°C. Cells were then washed with 1 × PBS, fixed 259 with 3% PFA, permeabilized with 0.1% Triton X-100 in 1 × PBS and incubated for 1 h with 260 5% BSA / 0.5% Tween 20 in 1 × PBS. To visualize HCoV-NL63 adhesion, cells were incubated for 2 h at room temperature with mouse anti-NL63-N IgG (0.25 μg ml -1 ; Ingenansa, 262 Spain), followed by a 1 h incubation with Alexa Fluor 488-labeled goat anti-mouse IgG
263
(2.5 μg ml -1 , Life Technologies, Poland). Nuclear DNA staining was performed with DAPI 264 (0.1 μg ml -1 , Sigma-Aldrich, Poland). Immunostained cultures were mounted on glass slides HCoV-NL63 was incubated with tested compounds for 1 h at 4°C, and virus adherence was 285 examined as described above. To assess HCoV-NL63 replication, cells were washed with 1 × PBS and infected with virus pre-incubated with HS at a TCID 50 ml -1 of 100. Following a 287 2 h incubation at 32 °C, unbound virus was removed by washing with 1 × PBS and fresh 288 medium containing HS was added to each well. Samples of cell culture supernatant were 289 collected 6 days post-infection and analyzed in a real-time PCR assay. 298 Human cell lines expressing the ACE2 protein were used to determine whether surface 299 expression of ACE2 is sufficient for HCoV-NL63 entry. Both ACE2 + and WT A549 300 and 293T cells were infected with HCoV-NL63 and cultured for 6 days at 32°C. Infection of 301 A549_ACE2 + cells resulted in clear CPE at 3 days p.i.; no CPE was observed in 302 HCoV-NL63-infected A549_WT cells and 293T_WT/ACE2 + cells (Figures 2A and 2B,   303 respectively).
ACE2 acts as a receptor for HCoV-NL63 and is sufficient to enable infectious entry
304
Despite the apparent lack of CPE in HCoV-NL63-infected 293T_ACE2 + cells up to 305 7 days p. i., the virus replication was examined by Western blotting with antibodies specific 306 for the NL63-N protein. The results showed that viral protein was detectable in 293T_ACE2 + 307 and A549_ACE2 + cells, suggesting that expression of the ACE2 protein rendered these cell 308 lines permissive to infection by HCoV-NL63. No NL63-N protein was detected in WT cell 309 lines (Figure 3) .
Coronaviruses employ discontinuous replication strategy to generate sg mRNAs during 311 minus strand synthesis; these mRNAs are then copied into plus strand mRNAs. Plus stranded 312 sg mRNA molecules are formed exclusively during virus replication and may therefore serve 313 as markers for an active infection. Thus, we next examined WT and ACE2 + cells for the 314 presence of each HCoV-NL63 sg mRNAs after virus inoculation. As shown in Figure 4A , 315 HCoV-NL63 sg mRNAs were formed in A549 and 293T cell lines expressing the ACE2 Adhesion of HCoV-NL63 to mammalian cells 327 Next, a set of experiments to determine whether ACE2 serves as an attachment factor 328 for HCoV-NL63 was performed. To address this, A549_WT and A549_ACE + cells were 329 incubated at 4°C with gradient-purified HCoV-NL63 and virus adhesion to the cell surface 330 was examined using flow cytometry. The virus bound to both cell lines, suggesting that a cell 331 surface molecule other than ACE2 must be responsible for adhesion (Figure 5) . 332 Similarly, naturally permissive, normal and PMA-treated (31) LLC-Mk2 cells were 333 incubated at 4°C with gradient-purified HCoV-NL63 and virus adhesion to cell surface was 334 examined by flow cytometry. Even though PMA-mediated ACE2 scission inhibited replication of HCoV-NL63 (Figure 6A) , we observed no difference in virus attachment to 336 normal and PMA-treated cells (Figure 6B) . Likewise, decrease in cell surface ACE2 protein 337 levels on LLC-Mk2 cells after PMA treatment was confirmed by flow cytometry 338 (Figure 6C) . 339 To confirm the flow cytometry results, we used confocal microscopy to examine 340 HCoV-NL63 adhesion to PMA-stimulated and normal LLC-Mk2 cells. A representative 341 image is presented in Figure 6D , which confirms that ACE2 shedding does not affect 342 HCoV-NL63 binding to the cell surface. 345 The results outlined above suggest that another molecule on the cell surface is 346 responsible for virion attachment. Therefore, the role of sialic acid in virus adhesion was 347 examined. To this end, HCoV-NL63 replication was analyzed in cells pre-incubated with 348 C. perfringens type V neuraminidase, which shows a broad specificity for sialic 349 acid-containing substrates (32). Flow cytometric analysis of HCoV-NL63 adhesion to 350 LLC-Mk2 cells pre-incubated with neuraminidase showed no difference between control cells 351 and cells lacking sialic acids and ACE2 (Figure 7A-C) . To ensure that sialic acid was 352 enzymatically removed, influenza virus was used as a positive control. As expected, a 353 significant inhibition of virus replication on A549 cells was observed after neuraminidase 354 treatment, as this common carbohydrate moiety represents a functional receptor for influenza 355 viruses (data not shown).
Sialic acid or sugars moieties do not function as attachment receptor for HCoV-NL63
356
Comparable experiments were undertaken to analyze whether lectins are responsible for (Figure 7D-H) . (Figure 8A) . 371 In order to analyze whether ACE2 protein participates in virus attachment process, interaction resulted in lack of virus binding also on ACE2 + cells; no difference between 376 ACE2 + and ACE2was noted (Figure 8A) . Flow cytometry results were further confirmed by 377 confocal microscopy (Figure 8B) . 378 Subsequent analysis showed that pre-incubation of the virus with HS results in a dose-379 dependent decline virus replication (Figure 9) . Taken together, obtained results show that interact with ACE2; however, another stimulus may be required to expose the RBD and 405 enable its interaction with the ACE2. That would suggest similar strategy as one employed by 406 HIV-1, where CD 4 binding by gp120 results in structural alteration of the viral protein, which 407 enables gp120 binding to co-receptors and subsequent entry (53).
Here, we showed that directed expression of ACE2 on cells previously resistant to 409 HCoV-NL63 infection renders them susceptible. Next, we examined whether viral adherence 410 was dependent upon the level of ACE2 expression. Comparative analyses using 411 gradient-purified virus, WT cells, and cells overexpressing ACE2 showed that although 412 ACE2 protein is a pre-requisite for virus infection, it does not affect binding of virions to the 413 cell surface. Also selective scission of the ACE2 protein from the cell surface does not affect 414 the virus-cell interaction.
415
These observations are consistent with those reports showing that NL63-S protein has 416 low affinity for ACE2, and suggest that another molecule/set of molecules may serve as 417 attachment factors. In some β-coronaviruses, sialic acid may function as such a factor; 418 however, we found that removing these surface molecules with neuraminidase had no effect 419 on HCoV-NL63 replication or attachment. Similarly, soluble sugars that should hinder the 420 interaction between the potential lectin-like domain and cellular glycoproteins did not affect 421 virus binding (33) (34) (35) .
422
It has been reported that some β and γ coronaviruses (SARS-CoV, culture adapted 423 MHV, IBV) employ HS proteoglycans for adhesion or entry to susceptible cells (48-50).
424
Therefore the adhesion of the virus was evaluated in the presence of HSa soluble receptor 425 analog. Apparently, this compound blocked the ability of HCoV-NL63 to bind to the cell 426 surface of susceptible cell showing that HS proteoglycans are responsible for virus binding on 427 cells. What is more, the presence of HS proteoglycans strongly enhances virus infection, 428 showing the relevance of the observed phenomena.
429
One may, however, question whether ability of HS binding was not acquired due to cell 430 culture adaptation, as described for other coronaviral species (49, 54, 55 (56, 57) .
436
In summary, we examined whether human ACE2 (the receptor for HCoV-NL63) also 437 serves as an attachment factor. HCoV-NL63 adhered equally well to ACE2-expressing and 
